Renzo Bagnati

Cholesterol nose-to-brain delivery as a possible therapeutic strategy in Huntington’s disease

Abstract Background Huntington’s disease (HD) is a genetically dominant neurodegenerative disorder characterized by several pathological mechanisms, including the disruption of brain cholesterol homeostasis. In several HD animal models, brain cholesterol biosynthesis and levels a...